CPBTD
GSK icon

Central Pacific Bank - Trust Division’s GSK GSK Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$605K Sell
12,560
-1,253
-9% -$64K 0.06% 268
2026
Q2 		$724K Sell
13,813
-4,997
-27% -$264K 0.07% 252
2026
Q1 		$1.04M Sell
18,810
-2,850
-13% -$154K 0.13% 166
2025
Q4 		$1.06M Sell
21,660
-2,950
-12% -$138K 0.13% 162
2025
Q3 		$1.06M Sell
24,610
-100
-0.4% -$3.91K 0.13% 168
2025
Q2 		$949K Buy
24,710
+300
+1% +$11.5K 0.12% 180
2025
Q1 		$946K Buy
24,410
+2,361
+11% +$86.4K 0.13% 158
2024
Q4 		$746K Sell
22,049
-300
-1% -$10.8K 0.1% 202
2024
Q3 		$914K Sell
22,349
-200
-0.9% -$8.18K 0.12% 191
2024
Q2 		$868K Hold
22,549
– – 0.1% 205
2024
Q1 		$957K Buy
+22,549
New +$930K 0.12% 191

Other funds holding GSK

KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

Central Pacific Bank - Trust Division's GSK Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its GSK (GSK) stake by 9.1% in Q3 2026, selling an estimated $64K and leaving 12,560 shares worth $605K. The position accounts for 0.06% of the portfolio, ranked #268.

Central Pacific Bank - Trust Division first reported a position in GSK in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.06M in Q4 2025. 31 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Central Pacific Bank - Trust Division held 12,560 shares of GSK worth $605K as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 1,253 GSK shares in Q3 2026, an estimated $64K.
  • GSK made up 0.06% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #268 holding.
  • Central Pacific Bank - Trust Division first reported a position in GSK in Q1 2024 and has held it in 11 quarters since.
  • Central Pacific Bank - Trust Division's GSK position peaked at $1.06M in Q4 2025.
  • 31 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.